Gilead Sciences INC GILEAD SCIENCES ORD SHS
Gilead Sciences INC GILEAD SCIENC.../ US3755581036 /
0QYQ
|
24/05/2024 18:04:40
|
Chg.
-
|
Volume |
Bid18:30:00 |
Ask18:30:00 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
66.42USD
|
-
|
6,526
Turnover: 96,741.02 |
-Bid Size: - |
-Ask Size: - |
117.59 bill.USD |
3.18% |
20.78 |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
4.54 USD |
24.04% |
| EPS Diluted: |
4.50 USD |
23.63% |
| Revenues per Share: |
21.76 USD |
-0.52% |
| Book Value per Share: |
18.26 USD |
7.36% |
| Cash Flow per Share: |
6.43 USD |
-11.67% |
| Dividend per Share: |
3.00 USD |
2.74% |
| Total |
in mill. |
|
| Revenues: |
27,116.00 USD |
-0.60% |
| Net Income: |
5,665.00 USD |
23.37% |
| Operating Cash Flow: |
8,006.00 USD |
- |
| Cash and Cash Equivalents: |
6,085.00 USD |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
20.78 |
17.84 |
| P/S Ratio: |
4.34 |
3.72 |
| P/BV ratio: |
5.17 |
4.44 |
| P/CF Ratio: |
14.68 |
12.61 |
| PEG: |
0.86 |
0.74 |
| Earnings Yield: |
4.81% |
5.60% |
| Dividend Yield: |
3.18% |
3.70% |
| Market Capitalization |
|
| Market Capitalization: |
117.59 bill. USD |
100.94 bill. USD |
| Free Float Market Cap.: |
- USD |
- USD |
| Market Cap. / Employee: |
- USD |
- USD |
| Shares Outstanding: |
1.25 bill. |
|
Profitability
| Gross Profit Margin: |
76.04% |
| EBIT Margin: |
28.05% |
| Net Profit Margin: |
20.89% |
| Return on Equity: |
24.90% |
| Return on Assets: |
9.12% |
Financial Strength
| Liquidity I / Cash Ratio: |
0.54% |
| Liquidity II / Quick Ratio: |
0.95% |
| Liquidity III / Current Ratio: |
1.43% |
| Debt / Equity Ratio: |
1.10% |
| Dynam. Debt / Equity Ratio: |
491.83% |
Efficiency
| Employees: |
- |
| Personal Expenses / Employee: |
- USD |
| Revenues / Employee: |
- USD |
| Net Income / Employee: |
- USD |
| Total Assets / Employee: |
- USD |
| * Fiscal Year End: |
31/12/2023 |
| Accounting Standard: |
US GAAP |
